血型鑑定市场规模、份额及成长分析（依产品类型、检测类型、技术、应用、最终用户及地区划分）－2026-2033年产业预测

全球血型检测市场规模预计在 2024 年达到 20.6 亿美元，从 2025 年的 22.5 亿美元增长到 2033 年的 45.2 亿美元，在预测期（2026-2033 年）内复合年增长率为 9.1%。

全球血型鑑定市场正经历显着成长，这主要得益于技术进步和医疗服务可近性的提高等多种因素。慢性病患者对输血的需求日益增长，以及器官移植需求的不断增加，都推动了市场扩张。基于PCR的方法、微阵列技术和大规模定序等创新技术显着提高了血型鑑定的准确性和效率。此外，全球医院、诊所和诊断中心的快速成长也推动了对这些服务的需求。人工智慧和自动化技术在血型鑑定流程中的应用将进一步提高诊断速度和准确性。然而，高成本、基础设施不足以及伦理方面的考虑等挑战可能会阻碍血型鑑定在部分地区的市场渗透。整体而言，血型鑑定市场前景乐观。

全球血型鑑定市场驱动因素

全球血型鑑定市场蓬勃发展，这得益于各国政府为促进捐血和提高输血安全而推出的各项措施。这些措施在提高公众对血型鑑定服务的认知度和可及性方面发挥关键作用，对市场前景产生了积极影响。此外，公共卫生宣传活动和对血型鑑定设备的财政支持也鼓励医疗机构采用先进的血型鑑定技术。随着这些措施的推进，血型鑑定技术的进步将拥有更有利的环境，最终将惠及整个医疗保健产业，并确保输血安全。

全球血型鑑定市场限制因素

全球血型鑑定市场面临严峻挑战，主要原因是检测结果不一致且难以保证结果的准确性。检测方法、试剂品质和操作人员技术水准的差异是造成结果可靠性不足的原因。这些不一致会危及病人安全，并可能损害血型鑑定流程的可靠性。因此，这些挑战可能会阻碍血型鑑定解决方案和服务的广泛应用和整合，从而限制该领域的发展。解决这些问题对于确保血型鑑定实践的有效性和可靠性至关重要。

全球血型鑑定市场趋势

全球血型鑑定市场正经历着从传统血清学检测方法向先进分子血型鑑定技术的重大转变。这一趋势的驱动力在于，人们对准确识别罕见或弱效血型抗原的需求日益增长，这在产前检测和需要多次输血的患者等复杂病例中至关重要。包括PCR和DNA定序在内的分子方法，在提高准确性的同时，最大限度地降低了同种免疫和输血反应的风险。随着医疗机构逐渐认识到这些创新技术的优势，血型鑑定产业正迎来收入成长，并有望满足病患和医疗专业人员不断变化的需求。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• Start-Ups分析
• 原料分析

全球血型鑑定市场规模（依产品/服务划分）及复合年增长率（2026-2033 年）

• 消耗品
  • 抗血清试剂
  • 抗人类球蛋白试剂
  • 试剂红血球
  • 血库生理食盐水水
• 装置
• 服务和软体

全球血型检测市场规模（依检测类型划分）及复合年增长率（2026-2033 年）

• ABO血型检测与Rh血型鑑定
• 抗体筛检
• HLA分型
• 交叉配对试验
• 依抗原类型

全球血型鑑定市场规模（依技术及复合年增长率划分）（2026-2033 年）

• 基于检测的方法
• 基于PCR和微阵列的技术
• 大规模平行定序
• 其他技术

全球血型鑑定市场规模（依技术及复合年增长率划分）（2026-2033 年）

• 分子分型方法
• 血清学检测
• 基于微阵列的分型
• 次世代定序

全球血型检测市场规模（依应用领域及复合年增长率划分）（2026-2033 年）

• 输血
• 器官移植
• 诊断测试

全球血型检测市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 血库
• 临床检查室
• 其他最终用户

全球血型检测市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Bio-Rad Laboratories, Inc.（United States）
• Ortho Clinical Diagnostics（United States）
• Quotient Limited（Switzerland）
• Immucor, Inc.（United States）
• Grifols SA（Spain）
• Bio-Techne Corporation（United States）
• DIAGAST（France）
• Tulip Diagnostics（India）
• AXO Science（France）
• Beckman Coulter, Inc.（United States）
• MTC Invitro Diagnostics（Germany）
• BAG Diagnostics GmbH（Germany）
• Rapid Labs Ltd.（United Kingdom）
• NG Biotech（France）
• Demeditec Diagnostics GmbH（Germany）
• Sero AS（Norway）
• Alcor Scientific Inc.（United States）
• Tulip Group（India）
• Medion Grifols Diagnostics AG（Switzerland）

结论与建议

Global Blood Group Typing Market size was valued at USD 2.06 Billion in 2024 and is poised to grow from USD 2.25 Billion in 2025 to USD 4.52 Billion by 2033, growing at a CAGR of 9.1% during the forecast period (2026-2033).

The global blood group typing market is witnessing significant growth due to various factors, including technological advancements and increasing healthcare access. The prevalence of chronic diseases that necessitate blood transfusions, along with a rising demand for organ transplants, is driving market expansion. Innovations such as PCR-based methods, microarray technologies, and massively parallel sequencing have markedly improved blood typing accuracy and efficiency. Additionally, the rapid proliferation of hospitals, clinics, and diagnostic centers globally enhances the demand for these services. The integration of AI and automation in blood typing processes further boosts diagnostic speed and precision. However, challenges such as high costs, inadequate infrastructure, and ethical considerations could hinder market penetration in various regions. Overall, the outlook for blood group typing remains robust.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Group Typing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Blood Group Typing Market Segments Analysis

Global Blood Group Typing Market is segmented by Product, Test Type, Technique, Technology, Application, End User and region. Based on Product, the market is segmented into Consumables, Instruments and Services & Software. Based on Test Type, the market is segmented into ABO Blood Tests & Rh Typing, Antibody Screening, HLA Typing, Cross-matching Tests and Antigen Typing. Based on Technique, the market is segmented into Assay-based Techniques, PCR-based and Microarray Techniques, Massively Parallel Sequencing and Other Techniques. Based on Technology, the market is segmented into Molecular Typing, Serological Typing, Microarray-based Typing and Next-generation Sequencing. Based on Application, the market is segmented into Blood transfusions, Organ transplants and Diagnostic testing. Based on End User, the market is segmented into Hospitals, Blood Banks, Clinical Laboratories and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Blood Group Typing Market

The Global Blood Group Typing market is experiencing growth driven by various government initiatives aimed at promoting blood donation and enhancing the safety of blood transfusions. These measures play a crucial role in raising awareness and improving access to blood typing services, thereby positively influencing market prospects. Additionally, public health campaigns and financial support for blood typing equipment are encouraging healthcare facilities to adopt cutting-edge technologies in blood typing. As these initiatives progress, they create a more conducive environment for advancements in blood group typing, ultimately benefiting the overall healthcare sector and ensuring the availability of safe transfusion practices.

Restraints in the Global Blood Group Typing Market

The Global Blood Group Typing market faces notable challenges due to inconsistencies in test results and difficulties in maintaining accurate outcomes. Variations in testing methods, the quality of reagents, and the skill levels of operators contribute to this lack of reliability. Such inconsistencies can pose risks to patient safety and undermine the credibility of blood typing processes. Consequently, these challenges may impede the wider acceptance and integration of blood group typing solutions and services, potentially limiting advancements in this sector. Addressing these issues is crucial for ensuring the efficacy and trustworthiness of blood group typing practices.

Market Trends of the Global Blood Group Typing Market

The Global Blood Group Typing market is experiencing a significant shift towards the adoption of advanced molecular blood typing techniques, moving away from traditional serological methods. This trend is driven by the increasing demand for precision in identifying rare and weak blood group antigens, which is crucial for complex cases like prenatal testing and patients requiring multiple transfusions. Molecular methods, including PCR and DNA sequencing, enhance accuracy while simultaneously minimizing the risks of alloimmunization and transfusion reactions. As healthcare providers recognize the benefits of these innovative technologies, the blood group typing industry is poised for revenue growth, responding to the evolving needs of patients and medical professionals alike.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Startup Analysis
• Raw Material Analysis

Global Blood Group Typing Market Size by Product & Service & CAGR (2026-2033)

• Market Overview
• Consumables
  • Antisera Reagents
  • Anti-human Globulin Reagents
  • Red Blood Cell Reagents
  • Blood Bank Saline
• Instruments
• Services & Software

Global Blood Group Typing Market Size by Test Type & CAGR (2026-2033)

• Market Overview
• ABO Blood Tests & Rh Typing
• Antibody Screening
• HLA Typing
• Cross-matching Tests
• Antigen Typing

Global Blood Group Typing Market Size by Technique & CAGR (2026-2033)

• Market Overview
• Assay-based Techniques
• PCR-based and Microarray Techniques
• Massively Parallel Sequencing
• Other Techniques

Global Blood Group Typing Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Molecular Typing
• Serological Typing
• Microarray-based Typing
• Next-generation Sequencing

Global Blood Group Typing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Blood transfusions
• Organ transplants
• Diagnostic testing

Global Blood Group Typing Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Blood Banks
• Clinical Laboratories
• Other End Users

Global Blood Group Typing Market Size & CAGR (2026-2033)

• North America (Product & Service, Test Type, Technique, Technology, Application, End User)
  • US
  • Canada
• Europe (Product & Service, Test Type, Technique, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Test Type, Technique, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Test Type, Technique, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Test Type, Technique, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Bio-Rad Laboratories, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quotient Limited (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Immucor, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DIAGAST (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tulip Diagnostics (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AXO Science (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MTC Invitro Diagnostics (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BAG Diagnostics GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rapid Labs Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NG Biotech (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Demeditec Diagnostics GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sero AS (Norway)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alcor Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tulip Group (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medion Grifols Diagnostics AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations